26 May 2013
Keywords: gsk, settles, augmentin, antitrust, litigation, glaxosmithkline, says
Article | 19 July 2004
GlaxoSmithKline says that it has agreed to settle US antitrust casesinvolving the antibiotic product Augmentin (clavulanate).
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 2004
24 May 2013
© 2013 thepharmaletter.com